person · Reporting owner
DAO-HADDOCK QUYEN THI
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOCEPT INCBIOC · Entity 112149 | Director | November 17, 2022 | November 18, 2022 |
| Presidio Property Trust, Inc.NONE · Entity 8487 | Chief Accounting Officer | January 02, 2020 | January 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOCEPT INC
Report date November 17, 2022 · Filed November 18, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.81 · Expires 2032-11-16 | Direct | 10,000 |
Reported balance
After 2022-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-11-17 · Grant · Acquired 10,000 · Balance 10,000 F1: 1/3 of the shares subject to the option shall vest on each of November 17, 2023, November 17, 2024, and November 17, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: 1/3 of the shares subject to the option shall vest on each of November 17, 2023, November 17, 2024, and November 17, 2025.
Presidio Property Trust, Inc.
Report date January 02, 2020 · Filed January 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCK - SERIES ASEC Table I · non-derivative | Direct | 5,494 |
Reported balance
After 2020-01-02 transaction · row 1
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 3,000 · Balance 5,494 F1: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2022 Filed Nov 18, 2022 20:26 UTC | BIOCEPT INC BIOC · Entity 112149 | GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-22-058014 · doc4.xml · derivative · entry 1 DAO-HADDOCK QUYEN THI · CIK 0001764220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-11-16 F1 · derivative.exercise_date: 1/3 of the shares subject to the option shall vest on each of November 17, 2023, November 17, 2024, and November 17, 2025. Read SEC document |
| January 02, 2020 Filed Jan 2, 2020 12:00 UTC | Presidio Property Trust, Inc. NONE · Entity 8487 | GrantCOMMON STOCK - SERIES A | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-000024 · doc4.xml · nonDerivative · entry 1 DAO-HADDOCK QUYEN THI · CIK 0001764220 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,494 F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020. F1 · price: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.